October 5, 2023
D-SOLVE Consortium gathers momentum
In anticipation of the second international DeltaCure conference, the d-SOLVE Consortium convened for its second consortium meeting in Hannover. The gathering provided an opportune platform to showcase initial outcomes from their work packages and delve into vital aspects of collaboration.
The meeting saw the presentation of early results from various work packages. Participants engaged in comprehensive discussions to optimize strategies and strengthen collaboration, laying the groundwork for enhanced research outcomes.
A pivotal focus of the meeting was the discussion and fine-tuning of the protocol for the planned clinical study. Partners, alongside advisory boards, actively contributed to shaping a detailed protocol, a crucial milestone that will guide the consortium’s endeavors in the coming months.
October 5, 2023
D-SOLVE Consortium gathers momentum
In anticipation of the second international DeltaCure conference, the d-SOLVE Consortium convened for its second consortium meeting in Hannover. The gathering provided an opportune platform to showcase initial outcomes from their work packages and delve into vital aspects of collaboration.
The meeting saw the presentation of early results from various work packages. Participants engaged in comprehensive discussions to optimize strategies and strengthen collaboration, laying the groundwork for enhanced research outcomes.
A pivotal focus of the meeting was the discussion and fine-tuning of the protocol for the planned clinical study. Partners, alongside advisory boards, actively contributed to shaping a detailed protocol, a crucial milestone that will guide the consortium’s endeavors in the coming months.
October 5, 2023
D-SOLVE Consortium gathers momentum
In anticipation of the second international DeltaCure conference, the d-SOLVE Consortium convened for its second consortium meeting in Hannover. The gathering provided an opportune platform to showcase initial outcomes from their work packages and delve into vital aspects of collaboration.
The meeting saw the presentation of early results from various work packages. Participants engaged in comprehensive discussions to optimize strategies and strengthen collaboration, laying the groundwork for enhanced research outcomes.
A pivotal focus of the meeting was the discussion and fine-tuning of the protocol for the planned clinical study. Partners, alongside advisory boards, actively contributed to shaping a detailed protocol, a crucial milestone that will guide the consortium’s endeavors in the coming months.
